Source: Annual Congress 2004 - Viral bronchiolitis in children: what's new in diagnosis and treatment?
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Bibi, G. Yilena, F. David, S. David (Ashkelon, Jerusalem, Israel). A double blind study to determine the benefit of inhaled corticosteroids in bronchiolitis. Eur Respir J 2004; 24: Suppl. 48, 282

Member's Comments

No comment yet.

Related content which might interest you: For how much time and with which dose of inhaled steroids it is possible to maintain asthma control? A randomized prospective study Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 A randomized trial of the effectiveness of nebulized therapy with epinephrine compared with salbutamol in the treatment of acute viral bronchiolitis Source: Eur Respir J 2005; 26: Suppl. 49, 127s Year: 2005 Inhaled steroids doses to obtain asthma control in children: a randomised concurrent cohort study Source: Annual Congress 2009 - Clinical advances in childhood asthma Year: 2009 Meta-analysis of inhaled corticosteroids response in children with asthma. Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019 How to reduce COPD exacerbations with inhaled drugs? A pooled analysis of randomized trials Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Unlicensed use of high-dose inhaled corticosteroids in the UK occurs principally with fluticasone - an observational study of 26359 patients Source: Eur Respir J 2004; 24: Suppl. 48, 501s Year: 2004 Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 Three-year prospective cohort study of growth in asthmatic children prescribed appropriate inhaled corticosteroid (ICS) doses Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004 What to use INSTEAD of inhaled corticosteroids in COPD? Source: Eur Respir J 2014; 44: 1391-1393 Year: 2014 First line maintenance therapy for asthma: an observational study comparing inhaled corticosteroid monotherapy to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007 Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma Source: Eur Respir J 2016; 47: 981-984 Year: 2016 Withdrawal of high-dose inhaled corticosteroids in COPD patients with mild or moderate airflow limitation: a feasibility study in primary care. Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results Source: Eur Respir J 2009; 34: 641 Year: 2009 The effect of montelukast added to steroid on airway function as compared with steroid alone and placebo: a single blind, controlled study in acute asthma Source: Eur Respir J 2001; 18: Suppl. 33, 263s Year: 2001 The effects of nebulised bronchodilators and corticosteroids treatment compared with inhaled drug therapy for moderate COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 290s Year: 2004 Do infants with bronchiolitis get any benefit with nebulized salbutamol? Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy Year: 2011 Role of tiotropium in reducing exacerbations in COPD patients when added to long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS): The OUTPUL study Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013 Double blind, placebo controlled crossover study in COPD patients to assess the acute effect of budesonide/formoterol using HRCT and lung function tests Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Can we predict response of refractory asthmatic cough to tiotropium? :a prospective study Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020